Literature DB >> 2562181

Role of protein phosphatases in malignant transformation.

M Nagao1, R Sakai, Y Kitagawa, I Ikeda, K Sasaki, H Shima, T Sugimura.   

Abstract

Many oncogene products are protein kinases and signals are transduced via phosphorylation of proteins. Similarly, protein-dephosphorylation may play a critical role in malignant cell transformation. We have cloned two catalytic subunits of ser/thr protein phosphatase (PP) type 2A, PP2A alpha, and PP2A beta, from a rat liver cDNA library. Both cDNAs encode peptides of 309 amino acids with a difference of only 8 amino acids between the two. All primary hepatocellular hyperplastic nodules or carcinomas, which were induced by a food carcinogen, 2-amino-3-methylimidazo[4,5-f]quinoline, showed up-regulation of expression of the mRNAs of both PP2A alpha and PP2A beta. NIH3T3 cell transformants obtained by introducing activated c-raf, ret-II or Ki-ras oncogenes also showed high levels of PP2A alpha transcripts. Okadaic acid, a non-TPA type tumor promoter, was found to be a potent inhibitor of PP1 and PP2A. Its IC50 for PP1 was much higher than that for PP2A with phosphorylase a as a substrate. When raf and ret-II transformants were cultured with okadaic acid at 8 ng/ml for 2 days, both transformants became flattened and showed strict contact inhibitions. This flat cell morphology was stable for at least one month in the presence of okadaic acid, but in its absence, the cells reverted to their original transformed shape within 7-10 days. Colony formation by raf and ret-II transformants in soft agar was inhibited dose-dependently by okadaic acid; very few colonies grew in the presence of the acid at 8 ng/ml. Okadaic acid had less effect on a transformant of the Ha-ras gene, causing only 50% inhibition of colony formation at 8 ng/ml. The role of protein phosphatases in cellular transformation by certain oncogenes is suggested.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562181

Source DB:  PubMed          Journal:  Princess Takamatsu Symp


  4 in total

Review 1.  Viewing serine/threonine protein phosphatases through the eyes of drug designers.

Authors:  Mengmeng Zhang; S D Yogesha; Joshua E Mayfield; Gordon N Gill; Yan Zhang
Journal:  FEBS J       Date:  2013-09-05       Impact factor: 5.542

Review 2.  A tumor suppressor role for PP2A-B56alpha through negative regulation of c-Myc and other key oncoproteins.

Authors:  Hugh K Arnold; Rosalie C Sears
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

3.  Myosin phosphatase and RhoA-activated kinase modulate arginine methylation by the regulation of protein arginine methyltransferase 5 in hepatocellular carcinoma cells.

Authors:  Adrienn Sipos; Judit Iván; Bálint Bécsi; Zsuzsanna Darula; István Tamás; Dániel Horváth; Katalin F Medzihradszky; Ferenc Erdődi; Beáta Lontay
Journal:  Sci Rep       Date:  2017-01-11       Impact factor: 4.379

4.  Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics.

Authors:  Luc de Waal; Timothy A Lewis; Matthew G Rees; Aviad Tsherniak; Xiaoyun Wu; Peter S Choi; Lara Gechijian; Christina Hartigan; Patrick W Faloon; Mark J Hickey; Nicola Tolliday; Steven A Carr; Paul A Clemons; Benito Munoz; Bridget K Wagner; Alykhan F Shamji; Angela N Koehler; Monica Schenone; Alex B Burgin; Stuart L Schreiber; Heidi Greulich; Matthew Meyerson
Journal:  Nat Chem Biol       Date:  2015-12-14       Impact factor: 15.040

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.